Purity and integrity answer different quality questions. Absorbance-based measurements indicate how much RNA is present and whether contaminants may be affecting the sample, whereas gel or capillary electrophoresis shows whether RNA molecules remain intact or have been degraded. Considering both measurements prevents a concentrated sample with damaged or contaminated RNA from being treated as suitable.
Electrophoresis separates RNA according to size, so the resulting pattern provides a direct view of molecular integrity and degradation. An RNA Integrity Number, or RIN, condenses instrument-derived integrity information into a summary value. Together, these outputs help compare samples consistently and identify material that may compromise downstream measurements.
RNA integrity matters because degraded material may no longer preserve the original transcript representation. That distortion can influence reverse transcription, quantitative PCR, RNA sequencing, and broader transcriptome analysis, making differences between samples harder to interpret. Assessing integrity before these experiments helps distinguish changes associated with sample damage from biological changes in gene expression.
A damaged or inconsistent RNA sample can introduce variation that does not reflect the biology under study. Comparing concentration, contaminant indicators, and integrity information across samples helps investigators identify such technical differences before interpreting expression results. This is particularly important when deciding whether apparent gene-expression changes represent biological effects or unequal sample quality.
A practical workflow begins by measuring RNA concentration and indicators of contamination with an absorbance-based method. The sample is then examined by gel or capillary electrophoresis to evaluate molecular integrity, while an instrument may provide an RNA Integrity Number. Researchers can use the combined results to identify damaged samples and judge suitability for downstream experiments.
Measurements can identify damaged samples and make sample handling more consistent before downstream analysis. Concentration information supports comparable RNA input, while purity and integrity findings indicate whether a sample is suitable for the planned experiment. This standardization reduces avoidable technical variation and improves the basis for comparing reverse-transcription or gene-expression results.
The checks are especially relevant before reverse transcription, quantitative PCR, RNA sequencing, and transcriptome analysis. These methods depend on RNA that preserves representative transcript information and is not compromised by contaminants or degradation. Quality results therefore help researchers decide whether a sample can support the intended assay and interpret downstream measurements with greater confidence.